At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

PREEMPT-HF: PREcision Event Monitoring of Patients with Heart Failure Using HeartLogic™

Clinical Trial Title: 
PREEMPT-HF: PREcision Event Monitoring of Patients with Heart Failure using HeartLogic™.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Henry D. Huang, MD
Clinical Trial Protocol Description: 

The goal of the PREEMPT-HF study is to collect information from patients who have Boston Scientific devices with HeartLogic. This study will collect device information as well as clinical information from the patients to improve upon the HeartLogic™ Heart Failure sensor capabilities (such as predict heart failure events or help doctors treat heart failure events more quickly in the future) in patients diagnosed with heart failure who have an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D). Information will be collected from patients’ preexisting devices.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are 18 years of age or older.
  • Have been diagnosed with heart failure.
  • Have a Boston Scientific CRT-D or ICD device implant that has HeartLogic.
  • Are currently enrolled in LATITUDE.

This is a partial list of inclusion and exclusion criteria. To inquire about your eligibility, please call the contact number provided.

Clinical Trial Area: 
Heart and Vascular Conditions
Contact Phone: 
(312) 942-1604
Contact Name: 
Samia Majid